Preliminary report for vacuum wounds therapy by IQWiG in Germany

16

May 2019

For more than 20 years, vacuum therapy has been used on wounds in clinics, and over 100 studies have been completed. Nevertheless, statements about benefit and harm are to some extent uncertain because study leaders keep results under wraps.

According to the preliminary report on wounds healing by secondary intention, published by the Institute for Quality and Efficiency in Health Care IQWiG in August 2018, more than half of all participants in the manufacturer-funded studies had missing data. Also, 40% of Investigator Initiated Trials, studies, which were introduced by researchers working at universities, had missing data as well. At that time, IQWiG repeatedly requested this data in vain from the ones responsible.

Now that the manufacturer KCI (Acelity) has finally provided enough information, IQWiG sees a higher benefit in the negative pressure wound therapy (NPWT).

A systematic literature search for primary literature sources was carried out in the databases MEDLINE, Embase and Cochrane Central Register of Controlled Trials. In parallel, a search for relevant systematic reviews was carried out in the databases MEDLINE, Embase, Cochrane Database of Systematic Reviews and HTA Database. For the benefit assessment, a total of 12 randomized controlled trials (RCTs) and 16 nonrandomized trials were identified.

Results:

  • Wound healing: positive wound healing results have been reported in 14 studies. In the joint evaluation of the studies with moderate and high qualitative reliability of results, there was a statistically significant difference between the two treatment groups in favor of vacuum wounds therapy (OR: 1.56, 95% CI [1,15; 2,13]). Moreover, in the totality of all studies, the duration of wound healing was significantly lower in cases when the vacuum therapy was used
  • Reinterventions: results for the rate of reinterventions have been reported in 10 studies. In the joint evaluation of the studies with moderate and high qualitative reliability of results, there was a statistically significant difference in favor of vacuum therapy (OR: 0.46, 95% CI: [0.24, 0.86])
  • Length of hospital stay: in the meta-analysis, there was a statistically significant difference in favor of vacuum therapy both in the study with high-quality confidence (Llanos 2006) and in the totality of all studies (MD: -4.78, 95% CI: [-7.79 -1.76])
  • However, there was no statistically significant difference in the joint evaluation of the studies with moderate and high qualitative reliability of results concerning the mortality, bleeding, infection, amputation, pain, duration of stay in the intensive care unit, rehospitalization, health-related quality of life and function

At the same time as the final report on the wounds healing by secondary intention, the IQWiG published the preliminary report on the wounds healing by primary purpose. The preliminary report will be revised, sent to the Federal Joint Committee (the G-BA) as the final report and published on the IQWiG website eight weeks later.

The full details in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more